There are no reliable data on the potential teratogenic effects of tiliquinol/tilbroquinol in animals.
Nowadays, there is no pertinent data, nor in sufficient number, to evaluate a potential malformative or foetotoxic effect of this medicine when it is given during pregnancy.
Consequently, the use of medicine is not advised during pregnancy. If having systematic abortion is not recommended, this element leads to a careful attitude and a well positioned antenatal monitoring.
Contraindicated during breastfeeding.
Not applicable.
Increase of transaminases hepatic levels have been reported rarely, the majority of them were asymptomatic and decreased after treatment stopping.
Some rare skin reactions have been reported, either hypersensitive types (urticaria, Quincke’s oedema) or bullous types (fixed pigmented eruption).
Exceptionally, during prolonged treatments, peripheral neuropathies or optical nerve disorders have been reported.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
